Evidence map›Paper›PMID 34751245›Full record

ArticleFrontiers in cell and developmental biology2021

Extracellular Vesicles Secreted by TDO2-Augmented Fibroblasts Regulate Pro-inflammatory Response in Macrophages.

Kiel A Peck, Alessandra Ciullo, Liang Li, Chang Li, Ashley Morris, Eduardo Marbán, Ahmed Gamal Ibrahim

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kiel A PeckSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Alessandra CiulloSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Liang LiSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Chang LiSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Ashley MorrisSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Eduardo MarbánSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Ahmed Gamal IbrahimSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Cedars-Sinai Smidt Heart Institute · USCedars-Sinai Medical Center · US

Funding

Training in Advanced Heart Disease ResearchT32HL116273 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI Joshua I Goldhaber, EDUARDO MARBAN · 2013 to 2026
$5.6M
Macrophages as effectors of cell therapy for heart failureR01HL142579 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI IBRAHIM, AHMED · 2019 to 2023
$2.1M
NHLBI NIH HHS R01 HL142579
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are secreted lipid bilayer vesicles that mediate cell to cell communication and are effectors of cell therapy. Previous work has shown that canonical Wnt signaling is necessary for cell and EV therapeutic potency. Tryptophan 2,3-dioxygenase (TDO2) is a target gene of canonical Wnt signaling. Augmenting TDO2 in therapeutically inert fibroblasts endows their EVs with immunomodulatory capacity including attenuating inflammatory signaling in macrophages. Transcriptomic analysis showed that macrophages treated with EVs from fibroblasts overexpressing TDO2 had blunted inflammatory response compared to control fibroblast EVs.

Indexed as

exosomesextracellular vesiclesfibroblastsimmunoregulationinflammationmacrophagesTDO2

Identifiers

PMID34751245
PMCPMC8571098
OpenAlexW3212603901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.